Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Global Tensions Rise as NATO Rejects U.S. Iran Blockade Plan

NATO Cracks Over Strait of Hormuz as Allies Reject U.S. Blockade…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

U.S. Blockade of Strait of Hormuz Signals Rising Middle East Tensions

U.S. Blockade of Strait of Hormuz Raises Stakes in Standoff With…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Born Again or Left Behind: The Urgent Truth About His Soon Return

The Soon Return of Jesus Christ: Why Readiness Matters Now More…
Read more